Publication Ethics

Peer Review Process

Journal of Tropical Pharmacy and Chemistry is a peer-reviewed journal published two times a year since 2010. Articles in this journal should be written in Bahasa Indonesia and English, in 2018 all article must in English. Its focus on the issues of Pharmacy and allies. All submitted papers are put through double-blind review process. The journal accepts both research and non-research articles, which will be peer-reviewed by at least 2 (two) reviewers. Once a manuscript is submitted through the online process, a journal editor examines the manuscript and determines its appropriateness for the full peer review. If it passes the initial screening, the manuscript will be sent to two or more peer reviewers. The journals editorial board will then consider the peer reviewers reports and assemble the final decision to accept or reject the manuscript for publication.

Publication Ethics

Journal of Tropical Pharmacy and Chemistry  (J. Trop. Pharm. Chem.) is an international peer-reviewed journal in the area of pharmacy and chemistry fields from the Faculty of Pharmacy, Mulawarman University as an owner. This statement explains the ethical conduct to all parties/institutions elaborated in the manuscript publication Journal of Tropical Pharmacy and Chemistry, which includes the Editorial Board, Editor in Chief, the peer-reviewer, and the publisher (Faculty of Pharmacy, Mulawarman University), and the author(s). This statement is dependent on Practice Guidelines for publication as in Committee on Publication Ethics (COPE’s Best) [1].

The publication of an article in a peer-reviewed Journal of Tropical Pharmacy and Chemistry is an important unit framework in the development of a mutually sustainable and respected  knowledge network that is the result of direct exposure of the quality of the work of the authors and the institutions that support it. Peer-reviewed articles support and embody the scientific method. Therefore, it is expected that it is important to follow the standards of ethical behavior that apply to all parties involved in the act of publishing including authors, journal editors, peer reviewers, publishers, and the public.

Journal of Tropical Pharmacy and Chemistry takes its duty to maintain scientific records very seriously. Our journal programs record "scientific papers" and we recognize our responsibility as custodians of these "tracts" in all our policies, including the guidelines we have adopted to support editors, reviewers, and authors in carrying out their ethical duties. We are committed to ensuring that advertising, reprint, or other commercial revenue does not impact or influence editorial decisions. In addition, the Journal of Tropical Pharmacy and Chemistry will assist in communications with other journals and/or publishers that editors will find useful. Finally, we work with other publishers and industry associations to establish best practice standards on ethics, errors, and retractions--and stand ready to provide specific review and legal advice when needed.

Publication decisions

The Journal of Tropical Pharmacy and Chemistry editor is responsible for deciding which articles submitted to the journal should be accepted for publication. The validation of the work and its importance to researchers and readers should always drive those decisions. Editors may be guided by the policies of the journal's editorial board and limited by applicable legal requirements regarding defamation, copyright infringement, and plagiarism. The editor may confer with other editors or reviewers in making this decision. The journal uses Grammarly Plagiarism Checker to detect possible plagiarism in manuscript.

Fair play

An editor must evaluate manuscripts for their intellectual content without regard to the author’s race, gender, sexual orientation, religious beliefs, ethnic origin, nationality, or political philosophy.


Editors and any editorial staff must not disclose any information about submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisors, and the publisher, as appropriate.

Disclosure and conflicts of interest

  • Unpublished material disclosed in the submitted manuscript may not be used in the editor's own research without the written consent of the author.
  • Privileged information or ideas obtained through peer review must be kept confidential and not used for personal gain.
  • The editor should recuse themselves (i.e. should ask the co-editor, associate editor, or another member of the editorial board instead to review and consider) from considering manuscripts in which they have a conflict of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, company, or (possibly) an institutions related to the papers.
  • The editor should require all contributors to disclose relevant competing interests and publish corrections if the competing interests are revealed after publication. If necessary, other appropriate action should be taken, such as the publication of a retraction or a statement of concern.
  • It should be ensured that the peer-review process for sponsored supplements is the same as that used for the main journal. Items in sponsored supplements should be accepted solely on the basis of academic merit and readers interest and not influenced by commercial considerations.
  • Sections of the journal that are not peer-reviewed should be clearly identified.

Involvement and cooperation in investigations

An editor should take reasonable steps when an ethical complaints has been raised regarding a submitted manuscript or published paper, together with the publisher (or the public). Such steps will generally include contacting the authors of the manuscript or paper and giving consideration to the complaint or claim submitted, but may also include further communications to the relevant institutions and research bodies, and if the complaint is upheld, publication of corrections, retractions, expressions of concern, or other note, as may be relevant. Any reported act of unethical publishing behavior should be investigated, even if discovered years after publication.

Duties of Reviewers

Contribution to Editorial Decisions

Reviewer(s) assists the editorial team in making editorial decisions and through the editorial communications with authors. In addition, reviewer(s) can also assist authors in improving papers.


Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review is not possible must notify the editor and withdraw from the review process.


Any manuscripts received for review must be treated as confidential documents. They may not be shown or discussed with others except as permitted by the editors.

Standards of Objectivity

The review must be carried out objectively. Personal criticism of the author is inappropriate. Referees must express their views clearly with supporting arguments.

Acknowledgment of Sources

Reviewers should identify relevant published work that has not been cited by the author. Any statement that an observation, derivation, or argument has been previously reported must be accompanied by a relevant citation. Reviewers should also call to the editor's attention if there are substantial similarities or overlaps between the manuscript under consideration and other published papers of which they are personally aware.

Disclosure and Conflict of Interest

Privileged information or ideas obtained through peer review must be kept confidential and not used for personal gain. Reviewers should not consider manuscripts in which they have a conflict of interest resulting from competition, collaboration, or other relationships or connections with any authors, company, or institution associated with the papers.


Duties of Authors

Reporting standards

Authors of original research reports must present an accurate account of the work performed as well as an objective discussion of its significance. The underlying data should be represented accurately in the paper. Papers must contain sufficient detail and references to enable others to replicate the work. Fraudulent or intentionally inaccurate statements constitute unethical behavior and are unacceptable.

Data Access and Retention

Authors are required to provide raw data with respect to the paper for editorial review, and must be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if possible, and must, in any case, be prepared to retain the data for a reasonable time after publication.

Originality and Plagiarism

The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others that it has been properly cited or quoted.

Multiple, Redundant or Concurrent Publication

An author should not generally publish manuscripts describing substantially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal simultaneously is unethical and unacceptable publishing behavior.

Acknowledgement of Sources

Proper acknowledgment of the work of others should always be given. Authors should cite influentia publicationsl in determining the nature of the work reported.

Authorship of the Paper

Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the study being reported. Everyone who has made significant contribution should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they must be acknowledged or listed as contributors. Corresponding authors must ensure that all suitable co-authors and no inappropriate co-authors are listed in the paper, and that all co-authors have viewed and approved the final version of the paper and have approved its submission for publication.

Hazards and Human or Animal Subjects

Authors must clearly identify the chemicals, equipment, and procedures in the manuscript that pose any unusual hazards from their use. Procedures relating to humans or animals must be approved by the Ethics Committee and/or refer to standard procedures.

The author should ensure that the manuscript contains a statement that all procedures have been carried out in accordance with relevant legislation and institutional guidelines and that the appropriate institutional committee has approved them when the work use of animal or human subjects, Authors must include a statement in the manuscript that informed consent was obtained for experiments with human subjects. The right to privacy of human subjects always be observed.

For human subjects, authors must ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans [2].  All animal experiments must comply with the ARRIVE guidelines [3] and must be conducted in accordance with the U.K. Animals (Scientific Procedures) Act 1986 and related guidelines [4], or  EU Directive 2010/63/EU on the protection of animals used for scientific purposes [5], or the U.S. Public Health Service Policy on the Humane Care and Use of Laboratory Animals and, as applicable, the Animal Welfare Act [6].

Appropriate consents, permissions, and releases must be obtained if the author wish to include case details or other personal information or images of patients and other individuals in an Journal of Tropical Pharmacy and Chemistry publication. Written consent must be kept by the author and copies of the consent or proof that such consent has been obtained must be provided to Journal of Tropical Pharmacy and Chemistry upon request.

Natural Medicine Materials

Natural medicine materials must include the Latin name, author nomenclature, family name (in brackets), source, method of extraction/fractination for all collected materials used in the study. Otherwise, pharmacological evaluation of the materials must use a reference (positive control).


Disclosure and Conflicts of Interest

All authors must disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project must be disclosed.

Fundamental errors in published works

When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to immediately notify the editor of the journal or publisher and cooperate with the editor to retract or correct the paper.

Clinical trial studies

Clinical trials that match up to ICMJE uniform requirements [7] registered in a WHO public trials registry at or before the time of first patient enrolment have been approved for publication consideration. The trial registry name, URL website, and registration number must be included at the end of the abstract. Since Clinical Trials in general only consider clinical trials that evaluate methodological innovations for publication, we expect these trials to be registered, even though the primary endpoint may or may not be a "health outcome".

Journal of Tropical Pharmacy and Chemistry supports clinical trial transparency.  For relevant journals, authors are expected to follow to industry’s best standards in clinical trial registration and presentation, for example, the CONSORT guidelines, as further set out in the policies of the relevant journal [8]

Withdrawal of Manuscripts

Author are not allowed to recall submitted manuscripts, as such withdrawals are a waste of valuable resources that editors and referees spend a great deal of time processing submitted manuscript, and the work invested by the publisher.

If an author still requests a withdrawal of his/her manuscript while it is still in the peer-review process, the author will be penalized by paying $250 per manuscript, as a withdrawal penalty to the publisher. However, it is unethical to withdraw a submitted manuscript from one journal if it is received by another.

Withdrawal of manuscript after the manuscript is accepted for publication, the author will be punished by paying US$500 per manuscript. Manuscript withdrawal is only permitted after the withdrawal penalty has been paid in full to the Publisher. If the author does not agree to pay the fine, the author and his/her affiliates will be blacklisted for publication in this journal. In fact, his/her previously published articles will be removed from our online system.